000640Dong-A Socio Holdings000640 info
$89.33info0.08%24h
Global rank10780
Market cap$558.38M
Change 7d0.34%
YTD Performance17.33%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Dong-A Socio Holdings (000640) Stock Overview

    Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It develops DA-1241 for the treatment of type 2 diabetes and non-alcoholic steatohepatitis; DA-1726, an oxyntomodulin analogue to treat obesity; DA-1229, a dipeptidyl peptidase-4 inhibitor class treatment for type 2 diabetes; DA-8010, a muscarinic M3 receptor antagonist for the treatment of overactive bladder; DMB-3115, a biosimilar of Stelara and an inflammatory disease treatment; DA-3880 to treat anemia; STP0404, an HIV-1 treatment drug; and STP1002, an anti-cancer drug. The company also provides healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and derma business areas; CDMO services; imaging equipment and ENT workstation products; mineral water under the Cheonnyeonsu brand name; and IT and construction services. In addition, it produces glass bottles, PET, and corrugated cardboard boxes; engages in the foundry equipment, logistics, and food and beverage businesses. The company was founded in 1932 and is headquartered in Seoul, South Korea.

    000640 Stock Information

    Symbol
    000640
    Address
    64, Cheonho-daeroSeoul, 02587South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.donga.co.kr
    Country
    🇰🇷 South Korea
    Phone Number
    82 2 920 8114

    Dong-A Socio Holdings (000640) Price Chart

    -
    Value:-

    Dong-A Socio Holdings Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $89.33
    N/A
    Market Cap
    $558.38M
    N/A
    Shares Outstanding
    6.25M
    N/A
    Employees
    5.41K
    N/A
    Valuation
    2024
    Change
    P/FCF
    -74.44
    N/A
    Growth
    2024
    Change
    CAPEX
    -94.86M
    N/A
    Earnings
    2024
    Change
    Free Cash Flow
    -$7.50M
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org